The Cure and The Disease (part 2)
Date: Wednesday, June 24, 2020
The Cure and The Disease (part 2)
The Cure and the Disease (part 2) is the theme of this Executive Briefing in our “Analyzing Pandemics” series. Attendees will gain context and perspective regarding the biochemistry of the coronavirus and expert insights on vaccine and therapeutic solutions to fight COVID-19.
Detailed webinar instructions and materials available upon registration. COVID-19 pandemic resources available below.
Rest assured we do not sell your email address or other registration information.
The GIC’s mission is to provide a forum for a thoughtful, unbiased global dialogue on emerging issues that impact the economy, policy and geopolitics. During these challenging time related to the COVID-19 pandemic, we think it is important to share our content as a public service.
As a reminder, the Global Interdependence Center is a 501(c)(3) nonprofit organization. We rely on voluntary contributions to bring our high quality content to the public. If you enjoy and find our programming valuable, we encourage you to make a tax deductible donation of $25, $50, or $100 to GIC in support of future webinars and live conferences, or consider joining as a GIC Member.
Resources on COVID-19:
- COVID – 19: Health Recovery and Economic Recovery Go Hand in Hand, GIC Blog (June 1, 2020)
- COVID-19 Impacts and Philanthropic Opportunities: GGA Interview with Atlanta Fed President Raphael Bostic, GIC Blog (May 31, 2020)
- COVID-19 Playbook, Vital Strategies (May 2, 2020)
- About Masks, GIC Blog (April 24, 2020)
- COVID – 19: Health Recovery and Economic Recovery Go Hand in Hand, GIC Blog (April 21, 2020)
- PACT: Private Automated Contract Tracing, MIT (April 9, 2020)
- Review of Mobile Application Technology to Enhance Contact Tracing Capacity for COVID-19, Johns Hopkins Center for Health Security (April 8, 2020)
- FDA Has Authorized just one Coronavirus Antibody Test, CNN (April 7, 2020)
- A cost-effective way to help emerging markets fight Covid-19, GIC Blog (April 3, 2020)
- Contract Tracing Mobile Apps for COVID-19: Privacy Considerations and Related Trade-offs, Cornell (March 30, 2020)
- Weekly Economic Update by Michael Drury, GIC Blog (March 30, 2020)
- Why coronavirus antibody testing in one Colorado town could provide a way forward, ABC News (March 28, 2020)
- Worst-Case Estimates for U.S. Coronavirus Deaths, New York Times (March 13, 2020)
- First Ebola, Now Coronavirus. Why an Omaha Hospital Gets the Toughest Cases, New York Times (February 18, 2020)
- Enhancing Private Sector Health System Preparedness for 21-st Century Health Threats Foundational Principles from a National Academies Initiative, JAMA (February 6, 2020)
- NExT The Nebraska Transformational Project briefing sheet, University of Nebraska Medical Center (February 10, 2020)
Location: Virtual EventDownload iCal
Theresa Madaline, M.D.Healthcare Epidemiologist, Montefiore Health System
Dr. Madaline earned her medical degree from Thomas Jefferson University in 2008. She completed her Internal Medicine residency training at Mount Sinai in 2011 and graduated from the Einstein/Montefiore Infectious Diseases (ID) Fellowship program in 2013.
Barry Zingman, M.D.Clinical Director of Infectious Diseases at the Moses Division, Montefiore Health System
Dr. Barry Zingman is Clinical Director of Infectious Diseases at the Moses Division of Montefiore Medical Center; Medical Director of the Montefiore AIDS Center; Professor of Medicine at Einstein; and Principal Investigator at Montefiore/Einstein of the NIH Adaptive COVID-19 Treatment Trial (ACTT) of remdesivir and other therapies for people hospitalized with severe COVID-19 infection.
Andrew D. Racine, M.D., Ph.D.System Senior Vice-President and Chief Medical Officer of the Montefiore Health System and Executive Director of the Montefiore Medical Group
Andrew D. Racine, M.D., Ph.D. is the System Senior Vice-President and Chief Medical Officer of the Montefiore Health System and Executive Director of the Montefiore Medical Group. He holds appointments as Professor of Pediatrics at the Albert Einstein College of Medicine (AECOM) and Research Associate at the National Bureau of Economic Research (NBER) in Manhattan.